Healthcare & Life Sciences
Immunomedics
United Stateswww.immunomedics.com/
Immunomedics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Immunomedics
Immunomedics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Immunomedics develops antibody-drug conjugates (ADCs) designed to treat solid tumors and other types of cancer.
Explore Immunomedics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.